Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
14.88
+0.53 (3.69%)
At close: Apr 8, 2026, 4:00 PM EDT
14.75
-0.13 (-0.87%)
Pre-market: Apr 9, 2026, 7:58 AM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $1.25 billion as of April 9, 2026. Its market cap has increased by 357.64% in one year.
Market Cap
1.25B
Enterprise Value
1.19B
1-Year Change
357.64%
Ranking
Category
Stock Price
$14.88
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $1.25B, an increase of 329.78%. That is a compound annual growth rate of 15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.25B | 117.32% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.36B |
| Monte Rosa Therapeutics | 1.35B |
| Taysha Gene Therapies | 1.34B |
| Wave Life Sciences | 1.33B |
| Zenas BioPharma | 1.32B |
| Olema Pharmaceuticals | 1.32B |
| Novavax | 1.30B |
| MoonLake Immunotherapeutics | 1.22B |